About TRIO - Comprehensive Cancer Centers of Nevada
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at TRIO - Comprehensive Cancer Centers of Nevada
During the past decade, TRIO - Comprehensive Cancer Centers of Nevada conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk
2017-04-21
2017-07-15
Completed
52
Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
2017-05-12
2021-12-31
Unknown status
40
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "TRIO - Comprehensive Cancer Centers of Nevada"
#1 collaborator was "Janssen Biotech, Inc., including Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at TRIO - Comprehensive Cancer Centers of Nevada
According to Clinical.Site data, the most researched conditions in "TRIO - Comprehensive Cancer Centers of Nevada" are
"Graft Vs Host Disease" (1 trials), "Leukemia, B-cell" (1 trials), "Lymphoma, B-Cell" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "TRIO - Comprehensive Cancer Centers of Nevada" in a lesser frequency.
Clinical Trials Intervention Types at TRIO - Comprehensive Cancer Centers of Nevada
Most popular intervention types in "TRIO - Comprehensive Cancer Centers of Nevada" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (1 trials) and "pemigatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at TRIO - Comprehensive Cancer Centers of Nevada
The vast majority of trials in "TRIO - Comprehensive Cancer Centers of Nevada" are
2 trials for "All" genders.
Clinical Trials Status at TRIO - Comprehensive Cancer Centers of Nevada
Currently, there are NaN active trials in "TRIO - Comprehensive Cancer Centers of Nevada".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in TRIO - Comprehensive Cancer Centers of Nevada,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in TRIO - Comprehensive Cancer Centers of Nevada, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".